Creathor Ventures Invests In German BioTech Company Acousia To Fight Hearing Loss In 10€ Million Financing Round

Creathor Ventures announced today that it has, together with other investors, invested close to 10 €million in a Series B investment round in Acousia Therapeutics GmbH. Acousia is a Germany-based leader in the discovery and development of novel therapies in inner ear-related diseases and pathologies. The biotechnology company has developed drug candidates that will protect, repair and restore sensory hair cell function in patients suffering from hearing loss, caused by ototoxic drugs, normal aging process, noise and other conditions like sudden deafness.